Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
---|---|---|---|---|---|---|---|
BPS-82240 | 2 vials | - | - | - |
3 - 15 business days* |
20,452.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
ADAR1 Activity TWO-Luciferase Reporter HEK293 Cell Line is a HEK293 cell line designed to monitor... more
Product information "ADAR1 Activity TWO-Luciferase Reporter HEK293 Cell Line"
ADAR1 Activity TWO-Luciferase Reporter HEK293 Cell Line is a HEK293 cell line designed to monitor cell viability in parallel with ADAR1 (adenosine deaminase acting on RNA) enzyme activity. These cells were engineered to express ADAR1 (NM_001111.5) and an ADAR1 reporter construct. This construct is comprised of an ADAR1 hairpin target with a stop codon (UAG) susceptible to ADAR1-mediated editing to tryptophan (UUG), located upstream of a firefly luciferase reporter. In addition, they constitutively express Renilla Luciferase under the control of a CMV promoter, which can be used to determine cell viability. This cell line has been validated by treatment with ADAR1 siRNA and the ADAR1 inhibitor Fludarabine. The ADAR1 reporter construct is comprised of an ADAR1 hairpin target with a stop codon (UAG) upstream of the sequence encoding firefly luciferase. In the absence of ADAR1, firefly luciferase is not transcribed, and the cells show no firefly luciferase activity. However, these cells were engineered to express ADAR1, which converts adenine into inosine, now encoding the amino acid tryptophan (UUG) and enabling transcription and expression of firefly luciferase. ADAR1 activity, therefore, directly correlates with firefly luciferase activity. Renilla luciferase is constitutively expressed from a separate construct and therefore Renilla luciferase activity correlates with the number of cells, but not with ADAR1 activity.
Keywords: | ADAR, p136, IFI-4, ADAR1, DRADA, K88DSRBP, Interferon-inducible protein 4, 136 kDa double-stranded RNA-binding protein, Double-stranded RNA-specific adenosine deaminase, |
Supplier: | BPS Bioscience |
Supplier-Nr: | 82240 |
Properties
Application: | ADAR1 activity monitoring, inhibitor/activator studies, cell viability studies |
Species reactivity: | human |
Database Information
KEGG ID : | K12968 | Matching products |
UniProt ID : | P55265 | Matching products |
Gene ID : | GeneID 103 | Matching products |
Handling & Safety
Storage: | Liquid nitrogen |
Shipping: | -80°C (International: °C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed